Sustainability Home  > Governance Structure and Management Systems > Stakeholder Engagement

Governance Structure and Management Systems: Stakeholder Engagement

Bristol-Myers Squibb works with scientists, academia, government, patient advocacy groups, and other stakeholders to better understand areas of significant unmet medical needs within our area of competency and expertise. We foster communications and dialogue with stakeholders on our R&D strategy.

Defining Major Stakeholders

Our stakeholders are similar to those of other major corporations. They encompass interested parties, both internal and external to the company and include:

  • Customers and consumers
  • Employees and their families
  • Retirees
  • Shareholders and investor groups
  • Suppliers and contractors
  • Neighbors and community groups
  • Regulators, legislators, and political leaders
  • Non-governmental organizations (NGOs)
  • Academia

Approaches to Consultation

Bristol-Myers Squibb has a long tradition of open communication and cooperation with our stakeholders on environmental, social, and economic issues. This is a fundamental element of our Pledge. We invite questions and comments and pursue opportunities to partner with others. Understanding the wisdom, concerns, and lessons of our stakeholders helps improve our management of the company.

We have identified our key stakeholders and developed strategies for appropriately engaging with them. These dialogues—some new, some continuing, some expanding—help convey the importance of sustainability to our business, discuss the key issues facing our company and the healthcare industry, and review the actions we are taking on the social, environmental and economic fronts.

Internally, we foster communications and dialogue with employees through a variety of initiatives, including functional and cross-functional committees, state-of-the-business addresses, web-based communications on the Internet and intranet, and other publications.

Externally, we actively seek dialogue with stakeholders. For example, we work with external advisors — representing socially responsible investment groups, academia, key customers, and public interest groups — who review and comment on our progress toward sustainable development. We have a feedback section and a "frequently asked questions" page on our Sustainability website, as well as phone numbers to contact our local facilities around the world.

Bristol-Myers Squibb participates on several multi-stakeholder panels in public meetings. Sitting side-by-side with representatives of government, academia, NGOs, and industry, we discuss emerging issues, including sustainability reporting; environmental, health, safety, and social metrics; full cost accounting; and product life cycle management. Meetings such as these help to further the understanding of commonly shared challenges.

By working at the community level, while also involving countries and governments, Bristol-Myers Squibb has developed model programs that can be used around the world—from a UNAIDS endorsed curriculum for health professionals first developed by the Baylor College of Medicine in the SECURE THE FUTURE program for Africa that has now been utilized in 47 countries to university public health education courses focused on designing and executing HIV/AIDS response plans to the creation of the first ever Pediatric AIDS Corps for Africa. Benefits accrue to the communities by controlling disease transmission and ultimately, by building safety nets so that treatments can be delivered effectively.

In 2003, Bristol-Myers Squibb partnered with the World Resources Institute (WRI) and a group of large companies based in the northeast United States on a project to help corporations address climate change. This project, known as Climate Northeast, brought together a variety of businesses from different economic sectors. A report on the partnership’s activities, A Climate of Innovation: Northeast Business Action to Reduce Greenhouse Gases, is available to the public.

In partnership with the Hopewell Township, New Jersey, government, Bristol-Myers Squibb, which has a major research facility in the township, is addressing the impacts of business traffic on community life. It is a participant in a local public/private partnership—the Hopewell Valley Traffic Management Coalition—which seeks to balance quality-of-life issues with the demands of reasonable growth. The company and its partners have sought to minimize and reduce traffic flow by surveying existing patterns and then, in response, by offering flexible work hours to employees and encouraging car and van pools and the use of mass transit and park-and-ride facilities. A newly created Bristol-Myers Squibb Commuter Assistance Center will be the focal point of these efforts.

The company also participates in voluntary initiatives with regulatory authorities. For example, our facility in Lawrenceville, New Jersey, is a charter member in the U.S. Environmental Protection Agency (EPA) National Environmental Achievement Track Program. Our Wallingford, Connecticut, site became a participant in the U.S. EPA and Department of Energy Labs 21 Program for improving laboratory energy and water efficiency, encouraging the use of renewable energy sources, and promoting environmental stewardship.

Our facilities in Hopewell and Lawrenceville, New Jersey, have been accepted into the New Jersey Silver Track Program, which offers incentives — including regulatory flexibility — and public recognition to facilities able to demonstrate and measure improved environmental performance.

In addition, we encourage our employees to take an active part in sharing with others our company’s expectations and vision for sustainability. These conversations and actions within the community will help support positive change in our society.

Information Generated

The information generated through stakeholder dialogue covers a wide range of topics, including:

  • Best practices from other companies
  • Diverse expectations of performance from NGOs, governments, and academia
  • Feedback from customers on product and company performance
  • Opportunities for collaboration with local community organizations and governments
  • Community feedback on facility operations and emergency response procedures

Use of Information

We consider information resulting from stakeholder engagements in assessing our company’s sustainability performance and strategy, determining the scope and content of information shared with the public, and shaping the company's programs and actions.


Last updated October 27, 2006 . Italicized product names are registered trademarks of Bristol-Myers Squibb Company or one of its divisions or subsidiaries. Copyright © 1998-2006 Bristol-Myers Squibb Company. Your use of the information on this site is subject to the terms of our Legal Notices.

 

Also in this section:

Structure & Governance

Overarching Policies

Management Systems

On this page:

Defining Major Stakeholders

Approaches to Consultation

Information Generated

Use of Information

More information is available on:

Stakeholder Dialogue

Take our Survey

Provide Feedback on this Web Site

About this Report

Company profile

Pledge

Customer Information

Supplier Information

Contractor Information

Student Information

Members of the Community

Benchmarking

Awards

Glossary

Links